Loading viewer...
investor_presentation
Format: PDF investor_presentation
© 2018 Verisk Analytics, Inc. All rights reserved. 1 1Q2018 Earnings Presentation May 01, 2018
© 2018 Verisk Analytics, Inc. All rights reserved. 1
Earnings Presentation
May 01, 2018© 2018 Verisk Analytics, Inc. All rights reserved. 2
Forward Looking Statements, Safe Harbor & Non -GAAP Financial Measures
Forward -Looking Statements
This release contains forward -looking statements. These statements relate to future events or to future financial performance an d involve known and unknown risks,
uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be ma terially different from any future results, levels
of activity, performance, or achievements expressed or implied by these forward -looking statements. In some cases, you can ident ify forward -looking statements by the
use of words such as “may,” “could,” “expect,” “intend,” “plan,” “target,” “seek,” “anticipate,” “believe,” “estimate,” “pred ict,” “potential,” or “continue” or the negative of these
terms or other comparable terminology. You should not place undue reliance on forward -looking statements because they involve kn own and unknown risks, uncertainties,
and other factors that are, in some cases, beyond our control and that could materially affect actual results, levels of acti vity, performance, or achievements. Other factors
that could materially affect actual results, levels of activity, performance, or achievements can be found in Verisk’s quarte rlyreports on Form 10 -Q, annual reports on Form
10-K, and current reports on Form 8 -K filed with the Securities and Exchange Commission. If any of these risks or uncertainties materialize or if our underlying
assumptions prove to be incorrect, actual results may vary significantly from what we projected. Any forward -looking statement i n this release reflects our current views
with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to our operati ons, results of operations, growth strategy, and
liquidity. We assume no obligation to publicly update or revise these forward -looking statements for any reason, whether as a re sult of new information, future events,
Notes Regarding the Use of Non -GAAP Financial Measures
The company has provided certain non -GAAP financial information as supplemental information regarding its operating results. The se measures are not in accordance
with, or an alternative for, U.S. GAAP and may be different from non -GAAP measures reported by other companies. The company beli eves that its presentation of non -
GAAP measures, such as organic constant currency revenue, adjusted organic constant currency EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net
income from continuing operations, diluted adjusted EPS, and free cash flow, provides useful information to management and in vestors regarding certain financial and
business trends relating to its financial condition and results of operations. In addition, the company’s management uses the se measures for reviewing the financial results
Preview truncated — download the full document for the complete content.
conference
36 Pages
investor_presentation
Coronado Global Resources
Basilea Pharmaceutica 2020 Investor Presentation
investor_presentationinvestor_presentation
27 Pages
Basilea Pharmaceutica International Ltd.